Samantha Singer

Samantha Singer is an Entrepreneur-in-Residence at Third Rock Ventures and President and CEO of Abata Therapeutics. She previously served as the Chief Operating Officer of the Broad Institute and, before that, was an executive at Biogen. Singer also served as an Independent Director on the Board for Rodin Therapeutics, until the company was acquired by Alkermes.